Synthesis and antiviral activity of (Z)- and (E)-2,2-[bis(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines: second-generation methylenecyclopropane analogues of nucleosides. 2004

Shaoman Zhou, and Julie M Breitenbach, and Katherine Z Borysko, and John C Drach, and Earl R Kern, and Elizabeth Gullen, and Yung-Chi Cheng, and Jiri Zemlicka
Department of Chemistry, Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201-1379, USA.

The second generation of methylenecyclopropane analogues of nucleosides 5a-5i and 6a-6i was synthesized and evaluated for antiviral activity. The 2,2-bis(hydroxymethyl)methylenecyclopropane (11) was converted to dibromo derivative 7 via acetate 12. Alkylation-elimination of adenine (16) with 7 afforded the Z/E mixture of acetates 17 + 18, which was deacetylated to give analogues 5a and 6a separated by chromatography. A similar reaction with 2-amino-6-chloropurine (19) afforded acetates 20 + 21 and, after deprotection and separation, isomers 5f and 6f. The latter served as starting materials for synthesis of analogues 5b, 5e, 5g-5i and 6b, 6e, 6g-6i. Alkylation-elimination of N(4)-acetylcytosine (22) with 7 afforded a mixture of isomers 5c + 6c which were separated via N(4)-benzoyl derivatives 23 and 24. Deprotection furnished analogues 5c and 6c. Alkylation of 2,4-bis(trimethylsilyloxy)-5-methylpyrimidine (25) with 7 led to bromo derivative 26. Elimination of HBr followed by deacetylation and separation gave thymine analogues 5d and 6d. The guanine Z-isomer 5b was the most effective against human and murine cytomegalovirus (HCMV and MCMV) with EC(50) = 0.27-0.49 microM and no cytotoxicity. The 6-methoxy analogue 5g was also active (EC(50) = 2.0-3.5 microM) whereas adenine Z-isomer 5a was less potent (EC(50) = 3.6-11.7 microM). Cytosine analogue 5c was moderately effective, but 2-amino-6-cyclopropylamino derivative 5e was inactive. All E-isomers were devoid of anti-CMV activity, and none of the analogues was significantly active against herpes simplex viruses (HSV-1 or HSV-2). The potency against Epstein-Barr virus (EBV) was assay-dependent. In Daudi cells, the E-isomers of 2-amino-6-cyclopropylamino- and 2,6-diaminopurine derivatives 6e and 6h were the most potent (EC(50) approximately 0.3 microM), whereas only the thymine Z-isomer 5d was active (EC(50) = 4.6 microM). Guanine Z-derivative 5b was the most effective compound in H-1 cells (EC(50) = 7 microM). In the Z-series, the 2-amino-6-methoxypurine analogue 5g was the most effective against varicella zoster virus (VZV, EC(50) = 3.3 microM) and 2,6-diaminopurine 5h against hepatitis B virus (HBV, EC(50) = 4 microM). Adenine analogues 5a and 6a were moderately active as substrates for adenosine deaminase.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D003521 Cyclopropanes Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Shaoman Zhou, and Julie M Breitenbach, and Katherine Z Borysko, and John C Drach, and Earl R Kern, and Elizabeth Gullen, and Yung-Chi Cheng, and Jiri Zemlicka
December 2004, Journal of medicinal chemistry,
Shaoman Zhou, and Julie M Breitenbach, and Katherine Z Borysko, and John C Drach, and Earl R Kern, and Elizabeth Gullen, and Yung-Chi Cheng, and Jiri Zemlicka
January 2005, Journal of medicinal chemistry,
Shaoman Zhou, and Julie M Breitenbach, and Katherine Z Borysko, and John C Drach, and Earl R Kern, and Elizabeth Gullen, and Yung-Chi Cheng, and Jiri Zemlicka
March 2008, Bioorganic & medicinal chemistry,
Shaoman Zhou, and Julie M Breitenbach, and Katherine Z Borysko, and John C Drach, and Earl R Kern, and Elizabeth Gullen, and Yung-Chi Cheng, and Jiri Zemlicka
March 2003, Nucleosides, nucleotides & nucleic acids,
Shaoman Zhou, and Julie M Breitenbach, and Katherine Z Borysko, and John C Drach, and Earl R Kern, and Elizabeth Gullen, and Yung-Chi Cheng, and Jiri Zemlicka
June 2012, Bioorganic & medicinal chemistry,
Shaoman Zhou, and Julie M Breitenbach, and Katherine Z Borysko, and John C Drach, and Earl R Kern, and Elizabeth Gullen, and Yung-Chi Cheng, and Jiri Zemlicka
January 2007, Nucleosides, nucleotides & nucleic acids,
Shaoman Zhou, and Julie M Breitenbach, and Katherine Z Borysko, and John C Drach, and Earl R Kern, and Elizabeth Gullen, and Yung-Chi Cheng, and Jiri Zemlicka
January 1998, Journal of medicinal chemistry,
Shaoman Zhou, and Julie M Breitenbach, and Katherine Z Borysko, and John C Drach, and Earl R Kern, and Elizabeth Gullen, and Yung-Chi Cheng, and Jiri Zemlicka
July 1998, Antiviral chemistry & chemotherapy,
Shaoman Zhou, and Julie M Breitenbach, and Katherine Z Borysko, and John C Drach, and Earl R Kern, and Elizabeth Gullen, and Yung-Chi Cheng, and Jiri Zemlicka
August 1999, Antiviral research,
Shaoman Zhou, and Julie M Breitenbach, and Katherine Z Borysko, and John C Drach, and Earl R Kern, and Elizabeth Gullen, and Yung-Chi Cheng, and Jiri Zemlicka
January 2005, Nucleosides, nucleotides & nucleic acids,
Copied contents to your clipboard!